Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress
Yolanda Diz-Chaves, Salvador Herrera-Pérez, Lucas C. González-Matías, et al.
Nutrients (2020) Vol. 12, Iss. 11, pp. 3304-3304
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach
Davide Arillotta, Giuseppe Floresta, Guy Pelletier, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 617-617
Open Access | Times Cited: 11
Exploring the Role of GLP-1 Receptor Agonists in Alzheimer’s Disease: A Review of Preclinical and Clinical Evidence
Lívia Cristina Ribeiro Teixeira, Marcelo R. Luizon, Karina Braga Gomes
Receptors (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access | Times Cited: 1
Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression
Jan Detka, Katarzyna Głombik
Pharmacological Reports (2021) Vol. 73, Iss. 4, pp. 1020-1032
Open Access | Times Cited: 47
Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
Yolanda Diz-Chaves, Zainab Mastoor, Carlos Spuch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9583-9583
Open Access | Times Cited: 37
Intestinal glucagon-like peptide-1: A new player associated with impaired counterregulatory responses to hypoglycaemia in type 1 diabetic mice
Fang-Xin Jin, Yan Wang, Min-Ne Li, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 8, pp. 1764-1777
Open Access | Times Cited: 7
IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target
Nicolaus Bruns, Elizabeth H. Tressler, Leandro F. Vendruscolo, et al.
Pharmacological Research (2024) Vol. 207, pp. 107312-107312
Open Access | Times Cited: 6
Roles for the gut microbiota in regulating neuronal feeding circuits
Kristie B. Yu, Elaine Y. Hsiao
Journal of Clinical Investigation (2021) Vol. 131, Iss. 10
Open Access | Times Cited: 39
Glucagon-like Peptide 1 Receptor Activation Inhibits Microglial Pyroptosis via Promoting Mitophagy to Alleviate Depression-like Behaviors in Diabetic Mice
Fan Yang, Xin‐shang Wang, Jingyu Qi, et al.
Nutrients (2022) Vol. 15, Iss. 1, pp. 38-38
Open Access | Times Cited: 27
Glucagon-like Peptide-1 Receptor Agonists in the Management of Type 2 Diabetes Mellitus and Obesity: The Impact of Pharmacological Properties and Genetic Factors
Jasna Klen, Vita Dolžan
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3451-3451
Open Access | Times Cited: 25
Insulin-resistance in paediatric age: Its magnitude and implications
Mohammed Al‐Beltagi, Adel Salah Bediwy, Nermin Kamal Saeed
World Journal of Diabetes (2022) Vol. 13, Iss. 4, pp. 282-307
Open Access | Times Cited: 25
Transforming Diabetes Care: The Molecular Pathways through Which GLP1-RAs Impact the Kidneys in Diabetic Kidney Disease
Merita Rroji, Goce Spasovski
Biomedicines (2024) Vol. 12, Iss. 3, pp. 657-657
Open Access | Times Cited: 5
Ion transporter cascade, reactive astrogliosis and cerebrovascular diseases
Md Shamim Rahman, Rabia Islam, Mohammad Iqbal H. Bhuiyan
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Exploring the therapeutic potential of GLP-1 receptor agonists in the management of obstructive sleep apnea: a comprehensive review
Amruth Akhil Alluri, Matthew Kurien, Nikhil Patel Pokar, et al.
Journal of Basic and Clinical Physiology and Pharmacology (2025)
Closed Access
The Intricate Relationship Between Circadian Rhythms and Gastrointestinal Peptides in Obesity
Filipe M. Ribeiro, Luiz Arnaldo, Lana Passos, et al.
Peptides (2025), pp. 171356-171356
Closed Access
Liraglutide Modulates ALCAT1-Mediated Cardiolipin Remodeling to Improve Cardiac Function in Obese Mice
Lulu Wang, Tingting Hu, Ruxuan Zhang, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 756, pp. 151583-151583
Closed Access
Evaluating the Molecular Interactions between Type 2 Diabetes Mellitus and Parkinson’s Disease: Role of Antidiabetic Drugs as Promising Therapeutics
Irum Waheed, Talal Sikandri, Sumbal Zaheen, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a systematic review and meta-analysis
Mohamed E. A. Mostafa, Tariq Alrasheed
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Semaglutide improves cognitive function and neuroinflammation in APP/PS1 transgenic mice by activating AMPK and inhibiting TLR4/NF-κB pathway
Yanyu Zhai, Kaili Lu, Yuan Yuan, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Effects of Glucagon-like peptide 1 (GLP-1) analogs in the hippocampus
Yolanda Diz-Chaves, Salvador Herrera-Pérez, Lucas C. González-Matías, et al.
Vitamins and hormones (2022), pp. 457-478
Closed Access | Times Cited: 17
Endocrine disrupting chemicals (EDCs) and the neuroendocrine system: Beyond estrogen, androgen, and thyroid
Heather B. Patisaul
Advances in pharmacology (2021), pp. 101-150
Closed Access | Times Cited: 22
Hormonal Regulation of Oxidative Phosphorylation in the Brain in Health and Disease
Katarzyna Głombik, Jan Detka, Bogusława Budziszewska
Cells (2021) Vol. 10, Iss. 11, pp. 2937-2937
Open Access | Times Cited: 22
Cyclic Adenosine Monophosphate in Cardiac and Sympathoadrenal GLP-1 Receptor Signaling: Focus on Anti-Inflammatory Effects
Anastasios Lymperopoulos, Jordana I. Borges, Renee A. Stoicovy
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 693-693
Open Access | Times Cited: 2
Control of human pancreatic beta cell kinome by glucagon‐like peptide‐1 receptor biased agonism
Jiannan Xiao, Liliane El Eid, Teresa Buenaventura, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 8, pp. 2105-2119
Open Access | Times Cited: 6
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges
C. Allard, Daniela Cota, Carmelo Quarta
Drugs (2023) Vol. 84, Iss. 2, pp. 127-148
Closed Access | Times Cited: 5
Potential new therapeutic target for Alzheimer's disease: Glucagon‐like peptide‐1
Xiao‐Yu Liu, Ni Zhang, Sheng‐Xiao Zhang, et al.
European Journal of Neuroscience (2021) Vol. 54, Iss. 10, pp. 7749-7769
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top